Waters Corp Stock Hits 52-Week High at $411.66 Amid Strong Growth

Published 01/21/2025, 11:30 PM
WAT
-

Waters Corporation (NYSE:WAT), a leading specialty measurement company with a market capitalization of $24.4 billion, has reached a new 52-week high, with its stock price soaring to $411.66. According to InvestingPro analysis, the company currently appears overvalued despite maintaining a "GOOD" overall financial health rating. This milestone reflects a significant uptrend in the company's market performance, underpinned by robust financial results and positive investor sentiment. Over the past year, Waters Corp has witnessed an impressive 29.47% increase in its stock value, with a notable 8.9% gain year-to-date, signaling strong confidence in the company's strategic direction and its ability to maintain growth amidst a dynamic market landscape. Investors are closely monitoring Waters Corp as it continues to innovate within the analytical science industry, with analyst price targets ranging from $340 to $430. InvestingPro subscribers have access to 12 additional investment tips and a comprehensive Pro Research Report, offering deeper insights into Waters Corp's valuation and growth prospects.

In other recent news, Waters Corporation has been in the spotlight, with significant developments in its financial performance and market outlook. The company has surpassed market expectations in its third quarter of 2024, demonstrating impressive growth across revenue, margins, and earnings per share (EPS). The company's revenue saw a 4% year-over-year increase, and non-GAAP EPS climbed to $2.93.

Analysts from Bernstein and TD Cowen have also shown positive sentiment towards the company. Bernstein upgraded Waters Corporation's stock rating from Market Perform to Outperform, citing the company's replacement cycle as a key growth driver. TD Cowen, on the other hand, increased its price target for Waters Corporation to $410.00, maintaining a Hold rating on the shares.

Moreover, the U.S. Commerce Department's new export controls on biotechnology equipment have affected Waters Corporation and other companies in the sector. These measures, aimed at preventing the use of U.S. technology by China in military applications, have led to a decline in the stock of Waters Corporation and other related companies.

These are recent developments that highlight the changes and challenges Waters Corporation is navigating. As the company continues to adapt to market conditions and regulatory changes, investors will be keenly watching its performance and strategies.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.